Malena Spar, Author at US Deprescribing Research Network

New Cohort of Junior Investigators Selected!

June 3, 2021

We are thrilled to announce our 2021-2022 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning opportunities to help fellows, post-docs, and early-stage faculty succeed with their deprescribing-related research and advance their research careers. This years cohort awardees include 13 outstanding physician, pharmacist, and PhD investigators from the US, Denmark, and Ireland. […]

New Cohort of Junior Investigators Selected! Read More »

Annual Meeting Registration Now Open!

March 16, 2021

The US Deprescribing Research Network’s 2nd Virtual Annual Meeting is now open for registration. The meeting with take place virtually on Thursday, May 27, 2021 from 11am-2pm ET. We hope you can join us! Click for agenda and registration

Annual Meeting Registration Now Open! Read More »

A Pharmacist-Led Randomized Controlled Trial to Assess Adverse Drug Events in Patients Discharged from the Hospital.

March 12, 2021

Gurwitz JH, Kapoor A, Garber L, et al. Effect of a Multifaceted Clinical Pharmacist Intervention on Medication Safety After Hospitalization in Persons Prescribed High-risk Medications: A Randomized Controlled Trial. JAMA Intern Med. Mar 2021. doi:10.1001/jamainternmed.2020.9285 A randomized clinical trial recently published in JAMA Internal Medicine sought to test the effects of a pharmacist-led intervention to

A Pharmacist-Led Randomized Controlled Trial to Assess Adverse Drug Events in Patients Discharged from the Hospital. Read More »

How can we improve deprescribing communication among patients with dementia and multiple chronic conditions?
A qualitative study in primary care lends key insights.

January 13, 2021

Green AR, et al. Designing a Primary Care-Based Deprescribing Intervention for Patients with Dementia and Multiple Chronic Conditions: A Qualitative Study. J Gen Intern Med. 2020 Dec;35(12):3556-63. DOI: 10.1007/s11606-020-06063-y. Researchers from Johns Hopkins University and Kaiser Permanente Colorado conducted a qualitative study to determine patient, caregiver, and physician preferences for discussing deprescribing in primary care

How can we improve deprescribing communication among patients with dementia and multiple chronic conditions?
A qualitative study in primary care lends key insights. Read More »

Application to form a Special Interest Group

January 10, 2021

The US Deprescribing Research Network seeks applicants to form special interest groups (SIGs) in order to encourage networking and collaboration on specific projects. These member-led SIGs should: Be centered around a product (e.g., submitting symposia for presentation at a national meeting, a paper, etc.) Have a structure with a defined leader Be open to all

Application to form a Special Interest Group Read More »

Now accepting applications: Junior Investigator Intensive Program

December 1, 2020

Apply now to be part of USDeN’s next cohort of Junior Investigator Intensive Program participants! The program will create a cohort of emerging leaders who are committed to pursuing research training and collaborative opportunities related to deprescribing. Applications due February 1, 2021. Learn more

Now accepting applications: Junior Investigator Intensive Program Read More »

New site selected for Data Harmonization Working Group

November 16, 2020

We are pleased to announce that Drs. Sean Hennessy and Allison Willis from the University of Pennsylvania will represent the 5th site for the Data Harmonization Working Group. The objective of this project is to develop and refine methods around creating, operationalizing, and implementing measures relevant to deprescribing studies across 5 institutions with different data

New site selected for Data Harmonization Working Group Read More »

When it’s better to stop or decrease health care services and interventions: researchers bring validity and transparency to deintensification recommendations in primary care.

November 9, 2020

Kerr EA, et al. Identifying recommendations for stopping or scaling back unnecessary routine services in primary care. JAMA Intern Med. 2020;180(11):1500-1508. doi:10.1001/jamainternmed.2020.4001 A recent study published in JAMA Internal Medicine examined and validated recommendations for avoiding unnecessary and excessive health care services in primary care settings. Dr. Eve Kerr and team at the University of

When it’s better to stop or decrease health care services and interventions: researchers bring validity and transparency to deintensification recommendations in primary care. Read More »

Which Outcome Measures are Most Commonly Used in Deprescribing Interventions?

September 4, 2020

Aubert C, et al. Outcome Measures for Interventions to Reduce Inappropriate Chronic Drugs: A Narrative Review. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16697 A new review study examined outcome measures used in deprescribing interventions. Primary author Carole Aubert, MD out of the University of Michigan and team first identified relevant measures and then sought to

Which Outcome Measures are Most Commonly Used in Deprescribing Interventions? Read More »

The OPTIMISE Randomized Clinical Trial: Deprescribing Antihypertensive Medications in Adults Aged 80 and Older and its Effect on Blood Pressure

June 3, 2020

Sheppard J, et al. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients with Hypertension Aged 80 Years and Older. JAMA. 2020; doi: 10.1001/jama.2020.4871 Researchers from the University of Oxford conducted a randomized, noninferiority, unblinded study to determine whether deprescribing antihypertensive medications in older patients had an effect on

The OPTIMISE Randomized Clinical Trial: Deprescribing Antihypertensive Medications in Adults Aged 80 and Older and its Effect on Blood Pressure Read More »

Malena Spar

Contact Us